JP2019511553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511553A5 JP2019511553A5 JP2018554360A JP2018554360A JP2019511553A5 JP 2019511553 A5 JP2019511553 A5 JP 2019511553A5 JP 2018554360 A JP2018554360 A JP 2018554360A JP 2018554360 A JP2018554360 A JP 2018554360A JP 2019511553 A5 JP2019511553 A5 JP 2019511553A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- composition
- inhibitor
- composition according
- dyrk1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662323583P | 2016-04-15 | 2016-04-15 | |
| US62/323,583 | 2016-04-15 | ||
| PCT/US2017/027734 WO2017181087A1 (en) | 2016-04-15 | 2017-04-14 | Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511553A JP2019511553A (ja) | 2019-04-25 |
| JP2019511553A5 true JP2019511553A5 (enExample) | 2020-06-11 |
| JP7278776B2 JP7278776B2 (ja) | 2023-05-22 |
Family
ID=60039311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554360A Active JP7278776B2 (ja) | 2016-04-15 | 2017-04-14 | 静止細胞標的化および有糸分裂の阻害剤を用いた新生物の処置のための組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10314843B2 (enExample) |
| EP (1) | EP3443351A4 (enExample) |
| JP (1) | JP7278776B2 (enExample) |
| KR (2) | KR102494172B1 (enExample) |
| CN (1) | CN109313197A (enExample) |
| AU (2) | AU2017248807A1 (enExample) |
| BR (1) | BR112018071023A2 (enExample) |
| CA (1) | CA3020978A1 (enExample) |
| IL (2) | IL292475A (enExample) |
| MX (2) | MX2018012508A (enExample) |
| WO (1) | WO2017181087A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10322128B2 (en) | 2016-04-15 | 2019-06-18 | Felicitex Therapeutics, Inc. | Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors |
| AU2024265078A1 (en) | 2023-05-04 | 2025-12-11 | Revolution Medicines, Inc. | Combination therapy for a ras related disease or disorder |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| US20250154171A1 (en) | 2023-10-12 | 2025-05-15 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2475368B1 (en) * | 2009-09-11 | 2014-12-17 | Amgen, Inc | N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridin yl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer |
| US20120184562A1 (en) | 2011-01-19 | 2012-07-19 | Kin-Chun Luk | 1,6- and 1,8-naphthyridines |
| US9446044B2 (en) * | 2011-08-19 | 2016-09-20 | Diaxonhit | DYRK1 inhibitors and uses thereof |
| FR2993317B1 (fr) | 2012-07-16 | 2014-08-15 | Snecma | Carter de turbomachine dans un materiau composite et procede de fabrication associe |
| RU2016117729A (ru) * | 2012-10-10 | 2017-11-10 | Фелиситекс Терапеутикс, Инк. | Терапия рака путем таргетинга покоящихся раковых клеток |
| EA201600003A1 (ru) * | 2013-06-11 | 2016-06-30 | Байер Фарма Акциенгезельшафт | КОМБИНАЦИИ ДЛЯ ЛЕЧЕНИЯ РАКА, СОДЕРЖАЩИЕ ИНГИБИТОР Mps-1 КИНАЗЫ И ИНГИБИТОР МИТОЗА |
| CA2854542A1 (en) * | 2013-06-18 | 2014-12-18 | 4Sc Discovery Gmbh | Method of inhibiting dyrk1b |
| US9566280B2 (en) * | 2014-01-28 | 2017-02-14 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
| MA39763A (fr) | 2014-03-20 | 2017-01-25 | Samumed Llc | Indazole-3-carboxamides 5-substitués, et préparation et utilisation de ceux-ci |
| US20170304313A1 (en) | 2014-10-06 | 2017-10-26 | Novartis Ag | Therapeutic Combination For The Treatment Of Cancer |
| CN108135871B (zh) * | 2015-07-23 | 2022-11-04 | 博蔚医药生物科技股份有限公司 | 阻断疾病的泛素化-蛋白酶体系统的胺萘醌化合物及医药组合物 |
| US10322128B2 (en) | 2016-04-15 | 2019-06-18 | Felicitex Therapeutics, Inc. | Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors |
-
2017
- 2017-04-14 CN CN201780037724.5A patent/CN109313197A/zh active Pending
- 2017-04-14 US US15/488,143 patent/US10314843B2/en active Active
- 2017-04-14 CA CA3020978A patent/CA3020978A1/en active Pending
- 2017-04-14 WO PCT/US2017/027734 patent/WO2017181087A1/en not_active Ceased
- 2017-04-14 IL IL292475A patent/IL292475A/en unknown
- 2017-04-14 BR BR112018071023A patent/BR112018071023A2/pt not_active Application Discontinuation
- 2017-04-14 EP EP17783296.1A patent/EP3443351A4/en not_active Withdrawn
- 2017-04-14 AU AU2017248807A patent/AU2017248807A1/en not_active Abandoned
- 2017-04-14 KR KR1020187033030A patent/KR102494172B1/ko active Active
- 2017-04-14 JP JP2018554360A patent/JP7278776B2/ja active Active
- 2017-04-14 MX MX2018012508A patent/MX2018012508A/es unknown
- 2017-04-14 KR KR1020237002817A patent/KR20230020560A/ko not_active Ceased
-
2018
- 2018-10-11 IL IL262325A patent/IL262325B/en unknown
- 2018-10-12 MX MX2022012146A patent/MX2022012146A/es unknown
-
2019
- 2019-06-10 US US16/436,305 patent/US20190290651A1/en not_active Abandoned
-
2021
- 2021-12-21 US US17/558,204 patent/US20220110941A1/en not_active Abandoned
-
2023
- 2023-08-08 AU AU2023214240A patent/AU2023214240A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019511553A5 (enExample) | ||
| IL292475A (en) | Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis | |
| JP2019511554A5 (enExample) | ||
| JP2010526098A5 (enExample) | ||
| CU20160167A7 (es) | Compuestos de pirazolopiridinas y pirazolopirimidinas útiles en el tratamiento de condiciones alérgicas y respiratorias | |
| MX372716B (es) | Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| PH12015502563A1 (en) | Bipyrazole derivatives as jak inhibitors | |
| EA201490357A1 (ru) | Индазолы | |
| NZ626942A (en) | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| JP2021501208A5 (enExample) | ||
| CL2013003073A1 (es) | Compuestos derivados de pirrolotriazinona o imidazotriazinona, inhibidores de pi3k; composicion farmaceutica que los comprende; combinacion farmaceutica; utiles en el tratamiento de enfermedades respiratorias, inflamatorias, autoinmune, neurologica, cancer, entre otras. | |
| MY155639A (en) | 2, 6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors | |
| MX375724B (es) | Compuestos y métodos para la inhibición de jak. | |
| JP2017511321A5 (enExample) | ||
| TN2018000119A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| JP2010528021A5 (enExample) | ||
| PE20130246A1 (es) | COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SINTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO | |
| EA201890094A1 (ru) | Производные полициклических амидов в качестве ингибиторов cdk9 | |
| AR098776A1 (es) | Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas | |
| MX2017005281A (es) | Etil n-boc piperidinil pirazolo piridonas como inhibidores de janus quinasa. | |
| EA201790603A1 (ru) | Ингибиторы гистондеметилазы | |
| JP2015520770A5 (enExample) | ||
| MY178136A (en) | Novel imidazopyridazine compounds and their use | |
| CY1118559T1 (el) | 2,6-διαμινο-πυριμιδιν-5-υλο-καρβοξαμιδια ως αναστολεις των κινασων συκ ή jak |